(TheNewswire)

Brossard, Québec, February 12, 2025 TheNewswire – Charbone Hydrogen Corporation (TSXV: CH; OTCQB: CHHYF; FSE: K47) (the ‘Company’ or ‘CHARBONE’), North America’s only publicly traded pure-play green hydrogen company, is pleased to announce the nomination of Mr. Jean-Claude Gonneau as a new Board member of Charbone, who will be elected at the Annual General and Extraordinary Meeting of Shareholders on March 28, 2025 .

Mr. Jean-Claude Gonneau is a seasoned executive and senior advisor with over 40 years of relevant experience. He has held key management and investment banking roles as the Founder and General Manager of Camden Associates, an award-winning investment banking boutique. Mr. Gonneau is a high-performing leader and a proven executive, specializing in developing and executing corporate and business development strategies in banking and investment banking, particularly in technology, Greentech, and biotech, as well as non-conventional energy and mining. He possesses extensive international experience, having worked at Duet Asset Management, SG Cowen, Donaldson Lufkin & Jenrette, First Boston Corporation, and BNP Paribas. Additionally, Mr. Gonneau is an excellent communicator with strong interpersonal and leadership skills. He has a successful track record in new business development, market development, strategic planning, fundraising, and executive marketing roles, and he has experience with start-ups, turnaround situations, and corporate strategy development.

Mr. Gonneau has also served as a board member for several publicly traded and private companies in Canada, the United States, and France.

As a seasoned senior executive and board member, Mr. Gonneau will provide exceptional complementary experience to the Board of CHARBONE.

Shares for Debts Issuance

CHARBONE is pleased to announce shares for debt settlements totaling $310,000 in management remuneration debts, including that of the Chief Executive Officer, through the issuance of 4,133,334 common shares at a deemed value of $0.075 per share .

To conserve its capital, the Corporation entered into debt settlement agreements with certain management members, including its Chief Executive Officer, to address remuneration debts. Any debt settlement will be formalized through an agreement and in accordance with Policy 4.4 – Security Based Compensation of the Exchange Corporate Finance Manual . The Shares for Debt are subject to acceptance by the Exchange and require disinterested shareholder approval, as the deemed value of the Common Shares to be issued exceeds $10,000 in aggregate per month. Any securities issued as part of a debt settlement will be subject to a statutory four-month hold period in Canada.

Update on the Amendment to Terms of Convertible Debentures

Following its news release dated June 10, 2024, announcing the agreement of principles to amend certain terms of the secured convertible debentures of the Company (each, a ‘Debenture’ ) originally issued in connection with a private placement totaling CA$1.2 million of 14% secured convertible debentures, and its release dated December 4, 2024, confirming that all requirements have been met, the Company is now pleased to announce receipt of the final approval from the TSX Venture Exchange. It has amended and issued new Debentures as of January 29, 2024, for an aggregate amount of $1,346,366, which will expire on October 31, 2025, featuring an annual interest rate of 12% and a conversion price of $0.10 per Debenture Share. Before the amendment, the expiry date was on October 7, 2024, the annual interest rate at 14% and the conversion price at $0.40 per Debenture Share.

Following the Exchange’s approval of the transaction, CHARBONE has issued 1,346,366 warrants to the Debenture holders. Each warrant entitles the holder to purchase one additional common share of the Company at an exercise price of $ 0.10 on or before October 31, 2025.

Grant of Common Share Purchase Options

CHARBONE is pleased to announce the grant of 5,200,000 common share purchase options of CHARBONE ( ‘ Options ‘ ) to directors and executives. These options are granted in accordance with the conditions of the CHARBONE stock option plan. Each Option allows its holder to purchase one common share of the Company for $0.15 per share for a period of two (2) years starting February 12, 2025.

About Charbone Hydrogen Corporation

CHARBONE is an integrated green hydrogen company focused on creating a network of modular green hydrogen production facilities across North America. Using renewable energy, CHARBONE produces eco-friendly dihydrogen (H2) for industrial, institutional, commercial, and future mobility users. CHARBONE is currently the only publicly traded pure-play green hydrogen company, with shares listed on the TSX Venture Exchange (TSXV: CH); the OTC Markets (OTCQB: CHHYF); and the Frankfurt Stock Exchange (FSE: K47). For more information on Charbone Hydrogen and its projects, please visit www.charbone.com

Forward-Looking Statements

This news release contains statements that are ‘forward-looking information’ as defined under Canadian securities laws (‘forward-looking statements’). These forward-looking statements are often identified by words such as ‘intends’, ‘anticipates’, ‘expects’, ‘believes’, ‘plans’, ‘likely’, or similar words. The forward-looking statements reflect management’s expectations, estimates, or projections concerning future results or events, based on the opinions, assumptions and estimates considered reasonable by management at the date the statements are made. Although Charbone believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements involve risks and uncertainties, and undue reliance should not be placed on forward-looking statements, as unknown or unpredictable factors could cause actual results to be materially different from those reflected in the forward-looking statements. The forward-looking statements may be affected by risks and uncertainties in the business of Charbone. These risks, uncertainties and assumptions include, but are not limited to, those described under ‘Risk Factors’ in the Corporation’s Filing Statement dated March 31, 2022, which is available on SEDAR at www.sedar.com; they could cause actual events or results to differ materially from those projected in any forward-looking statements.

Except as required under applicable securities legislation, Charbone undertakes no obligation to publicly update or revise forward-looking information.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release .

Copyright (c) 2025 TheNewswire – All rights reserved.

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the ‘Company’, ‘Sona’) is pleased to announce that its recently published findings from its ‘Targeted Intra-tumoral Hyperthermia with Uniquely Biocompatible Gold Nanorods Induces a Strong Immunogenic Cell Death in Two Immunogenically ‘Cold’ Tumors’ study will be presented at the international 19th Canadian Melanoma Conference on February 20th in Vancouver. Sona’s Chief Medical Officer, Dr. Carman Giacomantonio, a planning committee member for this conference, and Dr. Barry Kennedy, of The Giacomantonio Immuno-Oncology Research Group, will present both poster and oral presentations.

The conference is presented by OncologyEducation and is Canada’s flagship meeting on the research and treatment of melanoma, bringing together medical oncologists, surgeons, dermatologists, radiotherapists, pathologists, immunologists, molecular biologists and industry partners to review the latest research and explore new therapies.

About Sona Nanotech Inc.
Sona Nanotech is developing Targeted Hyperthermia, a photothermal cancer therapy, which uses therapeutic heat to treat solid cancer tumors. The heat is delivered to tumors by infrared light that is absorbed by Sona’s gold nanorods in the tumor and re-emitted as heat. Therapeutic heat (42-48°C) stimulates the immune system, shrinks tumors, inactivates cancer stem cells, and increases tumor perfusion – thus enabling drugs to reach all tumor compartments more effectively. Targeted Hyperthermia promises to be safe, effective, minimally invasive, competitive in cost, and a valuable adjunct to drug therapy and other cancer treatments.

Sona has developed multiple proprietary methods for the manufacture of gold nanoparticles which it uses for the development of both cancer therapies and diagnostic testing platforms. Sona Nanotech’s gold nanorod particles are cetyltrimethylammonium (‘CTAB’) free, eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This press release includes certain ‘forward-looking statements’ under applicable Canadian securities legislation, including statements regarding the anticipated applications and potential opportunities of Targeted Hyperthermia Therapy, and Sona’s preclinical and clinical study plans. Forward-looking statements are necessarily based upon a number of assumptions or estimates that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements, including the risk that Sona may not be able to successfully obtain sufficient clinical and other data to submit regulatory submissions, raise sufficient additional capital, secure patents or develop the envisioned therapy, and the risk that THT may not prove to have the benefits currently anticipated. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Sona disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Not for distribution to United States newswire services or for dissemination in the United States.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/240541

Silver47 Exploration Corp. (TSXV: AGA) (‘Silver47’ or the ‘Company), has identified anomalous concentrations of several elements listed by both the United States and Canada as ‘critical metals.’ Following the 2024 drill program, a full review of historic and recent drill assays was undertaken with a focus on critical mineral potential. In addition to the high-grade zinc-silver-gold-lead-copper defined in the inferred resource, elevated amounts antimony (Sb), gallium (Ga), niobium (Nb), and vanadium (V) were found to occur within the Dry Creek (DC) and West Tundra Flats (WTF) resource zones.

Highlights

• The highest grades of antimony, gallium and vanadium occurs at the Dry Creek zone with up to 6,230 parts per million (‘ppm’) (0.623%) antimony and 116.4 ppm gallium and 1110 ppm vanadium

• The most significant interval drilled at the Dry Creek zone was from hole DC18-77, which returned 6.8 metres of 2,928.4 ppm antimony, 81.7 ppm gallium, 938.7 g/t silver, 1.5 g/t gold, 3.5% zinc, 1.7% lead, 0.4% copper including;

  • 4.3 metres of 4,432.2 ppm antimony, 96.7 ppm gallium, 1434.8 g/t silver, 2.2 g/t gold 4.8% zinc, 2.3% lead and 0.5% copper

CEO Gary R. Thompson, stated: ‘The identification of gallium and antimony, among other critical minerals, within the resource zones has the potential to add significant value to our Red Mountain project. While we are focused on growing the silver-gold and base metals resource at Red Mountain, further assessment of these critical minerals, which are used in a myriad of high-tech applications, is planned to better understand the potential contribution that they may have on the project.’

High antimony and gallium assay values consistently occur within previously reported intervals of high-grade silver-zinc-gold-lead-copper massive sulfides and are distributed throughout the resources. Niobium and vanadium highs occur primarily in the western portion of Dry Creek.

Figure 1. Red Mountain Project Location.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10967/240529_ff4094c424382981_002full.jpg

Table 1. Select drilled intervals containing high antimony and gallium at the Dry Creek Zone.

Table 2. Select drilled intervals of high antimony and gallium at the West Tundra Flats Zone.

Notes: Reported intervals in Table 1 and 2 are drilled intervals not true widths.

Alex Walls, P.Geo., Vice President of Exploration, stated: ‘The high antimony and gallium content within both existing resource zones shows that there is more value to unlock at Red Mountain as we continue drilling to grow the already impressive polymetallic resource.’

China is the world’s largest producer of many critical minerals and has recently imposed a ban on the export of gallium, antimony, and other essential materials, further straining global supply chains. Critical minerals are vital to the economies of Canada and the U.S. and have now become a matter of national security, shedding light on the vulnerabilities within our supply chains. According to consultancy Project Blue, China controls 98.8% of the global supply of refined gallium, while China and Russia together dominate 70% of the world’s supply of antimony.

Gallium is used in a variety of high-tech and energy-efficient applications, including AI technologies, data centers, light-emitting diodes (LEDs), magnet manufacturing, semiconductors, microchips, clean energy solutions, consumer electronics, communications, and thin-film solar technologies.

Antimony plays a critical role in several military and industrial applications, such as fire-retardant materials, ammunition, night vision goggles, nuclear weapons, anti-tank missiles, and armor-piercing bullets. It is also essential in the production of infrared sensors, precision optics, laser sighting, explosive formulations, hardened lead for bullets and shrapnel, ammunition primers, tracer ammunition, tritium production, flares, military clothing, and communication equipment. Additionally, antimony is crucial in the creation of tungsten steel and the hardening of lead bullets.

About the Red Mountain VMS-SEDEX Project – Alaska, USA

Silver47’s flagship Red Mountain property covers 633 square kilometres of Alaska State-managed land 100 kilometres south of Fairbanks, Alaska. The project is well situated for infrastructure, 30 kilometres east of the community of Healy which has power, rail and state highway access to Alaska Route 3, providing a valuable connection to the port of Anchorage and tide water. The Company has an approved permit to conduct advanced exploration across the project.

Red Mountain hosts a NI 43-101 inferred mineral resource estimate of 15.6 Mt at 7% zinc equivalent (‘ZnEq’) for 1Mt of ZnEq or 335.7 g/t silver equivalent (‘AgEq’) for 168.6 Moz AgEq at the Dry Creek (DC) and West Tundra Flats (WTF) resource areas as combined open pit and underground. DC and WTF are the two most advanced mineralized zones at Red Mountain, with at least 20 additional mineralized prospects discovered on the property to date over the 60 kilometres of highly prospective geology.

For more information, see the Red Mountain NI 43-101 technical report titled ‘Technical Report on the Red Mountain VMS Property, Bonnifield Mining District, Alaska, USA’ dated January 12, 2024, prepared by Apex Geoscience Ltd., can be found on the Company’s website https://silver47.ca/ and SEDAR+.

Quality Assurance and Quality Control

Quality assurance and quality control (QAQC) protocols for drill core sampling at Red Mountain project followed industry standard practices. Core samples were typically taken at 1.0 metre intervals in mineralized zones, and 3.0 metre intervals outside of mineralized zones. Sample lengths were adjusted as necessary so as not to cross lithologic and mineralogic boundaries. QAQC check samples were inserted into the sample stream with one blank, one duplicate (coarse), and one certified reference material (CRM) occurring within every 20 samples. Drill core was cut in half, bagged, sealed and delivered directly to ALS Minerals Fairbanks, Alaska for transport to the ALS Minerals Laboratories labs in North Vancouver, British Columbia. ALS Minerals Laboratories are registered to ISO 9001:2008 and ISO 17025 accreditations for laboratory procedures. Core samples were analyzed at ALS Laboratory facilities in North Vancouver using four-acid digestion with an ICP-MS finish. Gold analysis was by fire assay with atomic absorption finish, or gravimetric finish for over-limit samples. Over-limits for silver, zinc, copper, and lead were analyzed using Ore Grade four-acid digestion. The standards, certified reference materials, were acquired from CDN Resource Laboratories Ltd. of Langley, British Columbia and selected to represent expected mineralization.

Qualified Person

Mr. Alex S. Wallis, P.Geo., is Vice President of Exploration for the Company who is a ‘qualified person’ as defined by National Instrument 43-101. Mr. Wallis has verified the data disclosed in this press release, including the sampling, analytical and test data underlying the technical information and has approved the technical information in this press release.

About Silver47 Exploration Corp.

Silver47 wholly-owns three silver and critical metals (polymetallic) exploration projects in Canada ‎and the US: the Flagship Red Mountain silver-gold-zinc-copper-lead VMS-SEDEX project in ‎southcentral Alaska; the Adams Plateau silver-zinc-copper-gold-lead SEDEX-VMS project in ‎southern British Columbia, and the Michelle silver-lead-zinc-gallium-antimony MVT-SEDEX ‎Project in Yukon Territory.‎ Silver47 Exploration Corporation shares trade on the TSX-V under the ticker symbol AGA. For ‎more information about Silver47, please visit our website at www.silver47.ca.‎

No securities regulatory authority has either approved or disapproved of the contents of this release. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

FORWARD-LOOKING STATEMENTS

Information set forth in this news release may involve forward-looking statements under applicable ‎‎securities laws. Forward-looking statements are statements that relate to future, not past, events. In this ‎‎context, forward-looking statements often address expected future business and financial performance, ‎and ‎often contain words such as ‘anticipate’, ‘believe’, ‘plan’, ‘estimate’, ‘expect’, and ‘intend’, ‎statements that ‎an action or event ‘may’, ‘might’, ‘could’, ‘should’, or ‘will’ be taken or occur, including ‎statements relating ‎to the trading of the Company’s common shares on the TSXV, the prospective ‎geology and composition of its properties, anticipated results of further exploration on its properties, ‎statements relating to the YESAB litigation, or other similar expressions and all statements, other than ‎statements of historical fact included ‎herein. By their nature, forward-‎looking statements involve known ‎and unknown risks, uncertainties and other factors which may cause our ‎actual results, performance or ‎achievements, or other future events, to be materially different from any ‎future results, performance or ‎achievements expressed or implied by such forward-looking statements. ‎Such factors include, among ‎others, the following risks: the need for additional financing; the satisfaction of ‎the conditions imposed ‎by the TSXV on the Listing; operational risks associated with mineral exploration; ‎regulatory risks; ‎fluctuations in commodity prices; title matters; litigation risks; and the additional risks identified in the ‎‎Company’s long form prospectus dated October 25, 2024 filed under its issuer profile on SEDAR+ and ‎other reports and filings with the TSXV and ‎applicable Canadian securities regulators. Forward-looking ‎statements are made based on management’s ‎beliefs, estimates and opinions on the date that ‎statements are made and the Company undertakes no ‎obligation to update forward-looking statements if ‎these beliefs, estimates and opinions or other ‎circumstances should change, except as required by ‎applicable securities laws. Investors are cautioned ‎against attributing undue certainty to forward-looking ‎statements.‎

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/240529